141st APHA Annual Meeting

In This section

277950
Pre-travel preparation of US business travelers: An analysis of the global travepinet consortium (GTEN), 2009-2011

Sunday, November 3, 2013

Nomana Khan, MBBS, MPH , Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA
Emily Jentes, PhD, MPH , Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA
Clive Brown, MD , Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA
Pauline Han, MA , Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA
Sowmya Rao, PhD , Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worchester, MA
Stefan Hagmann, MD, MSc , Division of Pediatric Infectious Diseases, Bronx-Lebanon Hospital Center, Bronx, NY
Regina LaRocque, MD, MPH , Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA
Edward Ryan, MD, DTM&H , Division of Infectious Disease, Massachusetts General Hospital, Boston, MA
Background: Occupational travel has increased over the last several decades. We describe demographics and travel characteristics of US business travelers (BT) compared with nonbusiness travelers (NBT) who visited participating sites for pre-travel care. Methods: Using an online tool, data were collected during pre-travel health consultations by Global TravEpiNet (GTEN) practitioners from 2009 to 2011. GTEN is a U.S. consortium of clinical practices specializing in travel medicine. Travelers self-defined travel purpose and were categorized as BT and NBT (i.e., leisure, visiting friends and relatives, adoption, receiving medical care, adventure, and attending large gatherings/events). Bivariate analysis was conducted using Wilcoxon Rank Sum tests and two-sided p<0.05 was considered significant. Results: Of 13,076 travelers, 2,810 (21%) were BT and 10,266 (79%) NBT. India was the top destination for both BT and NBT. BT were younger than NBT (median 41 vs. 45 years p≤0.0001). Forty-nine percent of BT indicated their employer suggested the consultation. The median time to seek consultations before departure for BT was 15 days, compared with 28 days for NBT (p≤0.0001). The median travel duration for BT was 10 days, compared with 14 days for NBT (p≤0.0001). When offered influenza vaccine, 48% of BT and 50% of NBT declined. Discussion: Compared with NBT, BT sought pre-travel advice closer to departure and traveled for shorter periods. BT and their employers should work to ensure timely pre-travel care, preferably 4-6 weeks before travel. Increased awareness and emphasis on importance of vaccination, especially influenza vaccine, can improve coverage and reduce illness in these travelers.

Learning Areas:
Epidemiology
Occupational health and safety
Protection of the public in relation to communicable diseases including prevention or control
Public health or related research

Learning Objectives:
Describe and compare demographic and travel characteristics of business and non-business travelers Analyze health interventions and advice given at Global TravEpiNet pre-travel consultations to expand the knowledge about pre-travel preparation of occupational travelers Identify gaps in the pre-travel preparations for US international business travelers

Keywords: Immunizations, International

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am an ORISE fellow with 3 years experience in the Division of Global Migration and Quarantine at CDC. I am the lead author on this abstract and have analyzed the data. I have an interest in infectious diseases and disease prevention.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.